Literature DB >> 21848709

Pleural fluid nucleic acid testing enhances pneumococcal surveillance in children.

Roxanne E Strachan1, Anita Cornelius, Gwendolyn L Gilbert, Tanya Gulliver, Andrew Martin, Tim McDonald, Gillian Nixon, Rob Roseby, Sarath Ranganathan, Hiran Selvadurai, Greg Smith, Manuel Soto-Martinez, Sadasivam Suresh, Laurel Teoh, Kiran Thapa, Claire E Wainwright, Adam Jaffé.   

Abstract

BACKGROUND AND
OBJECTIVE: National surveillance of invasive pneumococcal disease (IPD) includes serotyping Streptococcus pneumoniae (SP) isolates from sterile site cultures. PCR is more sensitive and can identify more SP serotypes (STs) in culture-negative samples. The aim of this study was to determine whether enhanced surveillance of childhood empyema, using PCR, provides additional serotype information compared with conventional surveillance.
METHODS: Pleural fluid (PF) from children with empyema were cultured and tested by PCR to identify SP, targeting the autolysin gene (lytA). Multiplex PCR-based reverse line blot assay was used to identify SP STs. Corresponding IPD surveillance and serotype data were obtained from the National Notifiable Diseases Surveillance System (NNDSS).
RESULTS: Eighty-nine children with empyema, aged ≤16 years, were recruited between April 2008 and March 2009, inclusive. SP was isolated from 5/84 (5.9%) PF cultures and by PCR in 43/79 (54.4%) PF samples. Serotypes were unidentifiable in 15 samples. The frequency of six serotypes (or serotype pairs) identified in 28 samples, including one with two serotypes, were: ST1, n = 4/29 (13.8%); ST3, n = 9/29 (31.0%); ST19A, n = 12/29 (41.4%); ST7F/7A, n = 1/29 (3.4%); ST9V/9A, n = 1/29 (3.4%); ST22F/22A, n = 2/29 (6.9%). Over the same period, 361 IPD patients, aged 16 years or less, were notified to NNDSS. Among 331 serotypeable NNDSS isolates (71.5% from blood), the frequencies of ST1 and 3 were significantly lower than in PF samples: ST1, n = 8/331 (2.4%; P < 0.05); ST3, n = 13/331 (3.9%; P < 0.0001).
CONCLUSIONS: The use of PCR to identify and serotype SP in culture-negative specimens provides additive information.
© 2011 The Authors. Respirology © 2011 Asian Pacific Society of Respirology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21848709     DOI: 10.1111/j.1440-1843.2011.02035.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  8 in total

Review 1.  Pneumococcal Capsules and Their Types: Past, Present, and Future.

Authors:  K Aaron Geno; Gwendolyn L Gilbert; Joon Young Song; Ian C Skovsted; Keith P Klugman; Christopher Jones; Helle B Konradsen; Moon H Nahm
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

Review 2.  Year in review 2012: lung cancer, respiratory infections, tuberculosis, pleural diseases, bronchoscopic intervention and imaging.

Authors:  José M Porcel; Chi Chiu Leung; Marcos I Restrepo; Kazuhisa Takahashi; Pyng Lee
Journal:  Respirology       Date:  2013-04       Impact factor: 6.424

3.  Increased paediatric hospitalizations for empyema in Australia after introduction of the 7-valent pneumococcal conjugate vaccine.

Authors:  Roxanne E Strachan; Thomas L Snelling; Adam Jaffé
Journal:  Bull World Health Organ       Date:  2012-12-11       Impact factor: 9.408

4.  Clinical outcome of parapneumonic empyema in children treated according to a standardized medical treatment.

Authors:  Marijke Proesmans; Brenda Gijsens; Patricia Van de Wijdeven; Herbert De Caluwe; Jan Verhaegen; Katrien Lagrou; Ellen Van Even; Francois Vermeulen; Kris De Boeck
Journal:  Eur J Pediatr       Date:  2014-05-17       Impact factor: 3.183

Review 5.  Pneumococcal empyema and complicated pneumonias: global trends in incidence, prevalence, and serotype epidemiology.

Authors:  M A Fletcher; H-J Schmitt; M Syrochkina; G Sylvester
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-02-23       Impact factor: 3.267

6.  Direct Streptococcus pneumoniae real-time PCR serotyping from pediatric parapneumonic effusions.

Authors:  Robert Slinger; Lucie Hyde; Ioana Moldovan; Francis Chan; Jeffrey M Pernica
Journal:  BMC Pediatr       Date:  2014-07-24       Impact factor: 2.125

Review 7.  How recent advances in molecular tests could impact the diagnosis of pneumonia.

Authors:  David R Murdoch
Journal:  Expert Rev Mol Diagn       Date:  2016-03-07       Impact factor: 5.225

8.  Aetiology of paediatric pneumonia after the introduction of pneumococcal conjugate vaccine.

Authors:  Mohamed A Elemraid; Andrew D Sails; Gary J A Eltringham; John D Perry; Stephen P Rushton; David A Spencer; Matthew F Thomas; Katherine M Eastham; Fiona Hampton; Andrew R Gennery; Julia E Clark
Journal:  Eur Respir J       Date:  2013-04-18       Impact factor: 16.671

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.